Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Anastrozole and cyproterone acetate treatment can help increase adult height in boys with testotoxicosis.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride increases CD8+ T cells in BPH tissues.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

The nanocrystalline suspension effectively delivers dutasteride over time with minimal inflammation.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

Some birth control pills increase blood clot risk; use them for specific conditions only.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

A new compound effectively inhibits human 5α-reductase 1.

Dutasteride may help shrink prostate cancer tumors.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Tamoxifen effectively treats gynecomastia without causing impotence.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.